Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety And Efficacy Of Normal Saline Flushing With And Without Heparin Lock In Maintaining Small Bore Intercostal Chest Catheter Patency
NCT06314620Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Mar 2024
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of heparin in pleural effusion (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoint: Rate of occlusions of intercostal chest catheter up to 30 days. Started Mar 2024; status: completed.
02
Drugs
heparin
03
Conditions
pleural effusion
Beyond the preview
Go deeper on NCT06314620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06314620.